Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $42,910 | 44 | 32.7% |
| Consulting Fee | $41,869 | 15 | 31.9% |
| Honoraria | $38,985 | 13 | 29.7% |
| Food and Beverage | $4,788 | 57 | 3.7% |
| Compensation for serving as faculty or as a speaker for a medical education program | $2,500 | 1 | 1.9% |
| Education | $22.76 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novocure Inc. | $111,755 | 104 | $0 (2024) |
| Novocure GmbH | $9,341 | 3 | $0 (2022) |
| Monteris Medical Corporation | $7,274 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,543 | 10 | $0 (2017) |
| Telix Pharmaceuticals | $132.62 | 1 | $0 (2023) |
| ABBVIE INC. | $16.66 | 1 | $0 (2022) |
| Novo Nordisk Inc | $11.44 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,078 | 6 | Novocure Inc. ($13,078) |
| 2023 | $27,217 | 20 | Novocure Inc. ($25,084) |
| 2022 | $44,395 | 16 | Novocure Inc. ($35,023) |
| 2021 | $7,153 | 7 | Novocure Inc. ($7,100) |
| 2020 | $8,300 | 5 | Novocure Inc. ($8,300) |
| 2019 | $5,547 | 15 | Novocure Inc. ($5,547) |
| 2018 | $6,846 | 15 | Novocure Inc. ($6,846) |
| 2017 | $16,539 | 47 | Novocure Inc. ($10,777) |
All Payment Transactions
131 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $132.14 | General |
| Category: Oncology | ||||||
| 05/23/2024 | Novocure Inc. | Optune (Device) | Consulting Fee | Cash or cash equivalent | $10,552.50 | General |
| Category: Oncology | ||||||
| 05/23/2024 | Novocure Inc. | Optune (Device) | Travel and Lodging | Cash or cash equivalent | $2,098.42 | General |
| Category: Oncology | ||||||
| 05/23/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $159.67 | General |
| Category: Oncology | ||||||
| 03/27/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $135.63 | General |
| Category: Oncology | ||||||
| 02/27/2024 | Monteris Medical Corporation | Neuroblate (Device) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Neuroblate | ||||||
| 12/29/2023 | Novocure Inc. | Optune (Device) | Honoraria | Cash or cash equivalent | $4,325.00 | General |
| Category: Oncology | ||||||
| 12/29/2023 | Novocure Inc. | Optune (Device) | Travel and Lodging | Cash or cash equivalent | $272.92 | General |
| Category: Oncology | ||||||
| 12/29/2023 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $144.15 | General |
| Category: Oncology | ||||||
| 12/28/2023 | Monteris Medical Corporation | Neuroblate (Device) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Neuroblate | ||||||
| 12/21/2023 | Novocure Inc. | OPTUNE LUA (NOVOTTF-200T) (Device) | Honoraria | Cash or cash equivalent | $7,035.00 | General |
| Category: Oncology | ||||||
| 12/21/2023 | Novocure Inc. | OPTUNE LUA (NOVOTTF-200T) (Device) | Travel and Lodging | Cash or cash equivalent | $1,789.08 | General |
| Category: Oncology | ||||||
| 11/18/2023 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $132.62 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 10/12/2023 | Novocure Inc. | — | Travel and Lodging | Cash or cash equivalent | $427.04 | General |
| 10/12/2023 | Novocure Inc. | — | Food and Beverage | Cash or cash equivalent | $92.11 | General |
| 10/12/2023 | Novocure Inc. | — | Food and Beverage | Cash or cash equivalent | $64.51 | General |
| 10/12/2023 | Novocure Inc. | — | Food and Beverage | Cash or cash equivalent | $61.38 | General |
| 10/12/2023 | Novocure Inc. | — | Food and Beverage | Cash or cash equivalent | $45.01 | General |
| 09/06/2023 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $69.22 | General |
| Category: Oncology | ||||||
| 08/23/2023 | Novocure Inc. | Optune (Device) | Consulting Fee | Cash or cash equivalent | $4,525.00 | General |
| Category: Oncology | ||||||
| 06/04/2023 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $16.41 | General |
| Category: Oncology | ||||||
| 02/01/2023 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $124.79 | General |
| Category: Oncology | ||||||
| 01/06/2023 | Novocure Inc. | Optune (Device) | Honoraria | Cash or cash equivalent | $5,025.00 | General |
| Category: Oncology | ||||||
| 01/06/2023 | Novocure Inc. | Optune (Device) | Travel and Lodging | Cash or cash equivalent | $661.88 | General |
| Category: Oncology | ||||||
| 01/06/2023 | Novocure Inc. | — | Travel and Lodging | Cash or cash equivalent | $300.73 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 26 | 50 | $32,240 | $6,723 |
| 2021 | 2 | 65 | 151 | $80,800 | $19,606 |
| 2020 | 3 | 52 | 125 | $49,932 | $10,723 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 26 | 50 | $32,240 | $6,723 | 20.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 44 | 116 | $66,780 | $16,435 | 24.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 35 | $14,020 | $3,172 | 22.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 19 | 70 | $26,392 | $5,872 | 22.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 21 | 39 | $19,436 | $3,980 | 20.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 16 | $4,104 | $870.61 | 21.2% |
About David Tran, MD PHD
David Tran, MD PHD is a Medical Oncology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1184747024.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Tran, MD PHD has received a total of $131,074 in payments from pharmaceutical and medical device companies, with $15,078 received in 2024. These payments were reported across 131 transactions from 7 companies. The most common payment nature is "Travel and Lodging" ($42,910).
As a Medicare-enrolled provider, Tran has provided services to 143 Medicare beneficiaries, totaling 326 services with total Medicare billing of $37,052. Data is available for 3 years (2020–2022), covering 6 distinct procedure/service records.
Practice Information
- Specialty Medical Oncology
- Other Specialties Medical Oncology
- Location Los Angeles, CA
- Active Since 04/07/2007
- Last Updated 11/10/2024
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1184747024
Products in Payments
- Optune (Device) $88,612
- Oncology (Device) $20,693
- OPTUNE LUA (NOVOTTF-200T) (Device) $8,824
- Neuroblate (Device) $7,274
- KISQALI (Drug) $1,131
- ILLUCCIX (Drug) $132.62
- QULIPTA (Drug) $16.66
- RYBELSUS (Drug) $11.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Los Angeles
Dr. Jacek Pinski, M.d, M.D
Medical Oncology — Payments: $882,931
Stephen Liu, Md, MD
Medical Oncology — Payments: $792,850
Matthew Rettig, Md, MD
Medical Oncology — Payments: $564,294
Mark Agulnik, Md, MD
Medical Oncology — Payments: $414,988
Dr. David Quinn, M.d, M.D
Medical Oncology — Payments: $304,638
Dr. Barbara Gitlitz, M.d, M.D
Medical Oncology — Payments: $68,433